Fig. 4From: Mortality reduction in pediatric patients with severe fatal human adenoviral pneumonia treated with high titer neutralizing antibodies (NAbs) plasma: a retrospective cohort studyTime to hospital discharge between plasma group and control group in survivorsBack to article page